Access My Breast Cancer Care App
Official title: Access my Breast Cancer Care - Use of an eHealth App in Navigating the Breast Cancer Trajectory: A Randomized Controlled Trial
Run by University of British Columbia · NCT07696637 · Data updated 2026-11-12
A breast cancer care app is being tested to see if it helps patients navigate care, feel more satisfied, and reduce in-person visits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 148 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 2 sites (Vancouver, British Columbia and 1 other locations) |
| Status | Recruiting |
| Started | April 20, 2026 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT07696637 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 19 years or older with breast cancer or a BRCA mutation undergoing breast reconstruction who have access to a smartphone or computer and can read English.
✕Probably not a fit
Individuals without access to compatible devices or who prefer not to use digital tools may see no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial tests whether the Access My Breast Cancer Care app improves patient-centered outcomes for adults with breast cancer or BRCA mutations undergoing reconstruction. The app provides educational resources, a calendar, symptom tracking, a customizable care pathway, a community forum, and a chat feature to support navigation and decision-making. Researchers will compare the app plus standard care to standard care alone, focusing on satisfaction with care, adverse events, and usability, and will use focus groups to capture patient perspectives. The study follows a cancer care framework to ensure the tool integrates effectively into cancer services and care pathways.
Why it matters
Potential benefit: If successful, the app could improve patients’ satisfaction, streamline care navigation, and reduce unnecessary clinic visits.
How similar studies have gone: Previous work in digital navigation tools for cancer care has shown potential improvements in patient experience, with variable effects on clinical outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * You are at least 19 years of age (the team only treats adult patients) * You have a diagnosis of breast cancer, or a BRCA mutation, and will be -having breast surgery with reconstruction (the app is tailored the breast cancer journey) * You have access to a smartphone or computer (individuals participating in the study will require access to a smart phone or computer to access the application if randomized to the intervention group) * Must have basic reading skills in English (the app is only available in English language) Exclusion Criteria: * You do not have access to a smartphone or computer (a computer or smart phone is required to access the application) * You are \<19 years of age (the team does not treat pediatric patients) * You do not have breast cancer or a BRCA mutation (the application is specific to the breast cancer journey) * You decline breast reconstruction (the application was designed by the plastics and reconstructive team, and with the app being in an infancy stage, the bulk of the content focuses on breast reconstruction surgery) * You are not able to read English (the app is only available in English language)
Where it's running
-
Providence Health Care
Vancouver, British Columbia, Canada Recruiting -
Vancouver Coastal Health
Vancouver, British Columbia, Canada Recruiting
Study contacts
- Study coordinator: Selena Banser Clinical Nurse Specialist, RN
- Email: selena.banser@vch.ca
- Phone: 236-997-9112
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EndoBreast: Feasibility and outcomes of nipple-sparing endoscopic mastectomy with immediate reconstruction
This observational study tests whether endoscopic nipple-sparing mastectomy with immediate reconstruction is feasible and acceptable for women at risk or with breast cancer.
-
Autologous Fat Grafting vs DIEP flap for reconstructed breast after radiation
This study tests whether autologous fat transfer can provide similar satisfaction and safety to the DIEP flap procedure for women needing breast reconstruction after mastectomy and radiation.
-
Prehabilitation with physiotherapy and mechanical stimulation before LD flap breast reconstruction
This study tests whether prehabilitation with physiotherapy and mechanostimulation improves shoulder pain and mobility for women undergoing breast reconstruction with a latissimus dorsi flap.
-
Fat grafting plus latissimus dorsi muscle flap for delayed breast reconstruction
This will try adding fat grafting to a latissimus dorsi muscle flap to rebuild breasts in women who previously had a mastectomy.
-
Hypofractionated radiotherapy after prosthetic breast reconstruction
This study tests whether a shorter, higher-dose radiotherapy course (HFRT) works as safely and effectively as the standard longer course (CFRT) for patients who had a mastectomy with implant reconstruction.
-
Implant-based breast reconstruction after bariatric (weight-loss) surgery
This registry-based project will use national data to see how common breast implants are and whether women who've had bariatric weight-loss surgery have different complication rates after implant-based breast augmentation or reconstruction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.